ArticleMolecular cancer therapeutics2022

Colchicine-Binding Site Agent CH-2-77 as a Potent Tubulin Inhibitor Suppressing Triple-Negative Breast Cancer.

Shanshan Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.